The crystal structure of the hydrolase domain of 10-formyltetrahydrofolate dehydrogenase - Mechanism of hydrolysis and its interplay with the dehydrogenase domain

被引:29
作者
Chumanevich, AA [1 ]
Krupenko, SA [1 ]
Davies, C [1 ]
机构
[1] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
关键词
D O I
10.1074/jbc.M313934200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
10-Formyltetrahydrofolate dehydrogenase (FDH) converts 10-formyltetrahydrofolate, a precursor for nucleotide biosynthesis, to tetrahydrofolate. The protein comprises two functional domains: a hydrolase domain that removes a formyl group from 10-formyltetrahydrofolate and a NADP(+)-dependent dehydrogenase domain that reduces the formyl to carbon dioxide. As a first step toward deciphering the catalytic mechanism of the enzyme, we have determined the crystal structure of the hydrolase domain of FDH from rat, solved to 2.3-Angstrom resolution. The structure comprises two domains. As expected, domain 1 shares the same Rossmann fold as the related enzymes, methionyl-tRNA-formyltransferase and glycinamide ribonucleotide formyltransferase, but, unexpectedly, the structural similarity between the amino-terminal domain of 10-formyltetrahydrofolate dehydrogenase and methionyl-tRNA-formyltransferase extends to the C terminus of both proteins. The active site contains a molecule of beta-mercaptoethanol that is positioned between His-106 and Asp-142 and that appears to mimic the formate product. We propose a catalytic mechanism for the hydrolase reaction in which Asp-142 polarizes the catalytic water molecule and His-106 orients the carbonyl group of formyl. The structure also provides clues as to how, in the native enzyme, the hydrolase domain transfers its product to the dehydrogenase domain.
引用
收藏
页码:14355 / 14364
页数:10
相关论文
共 52 条
[1]   STRUCTURES OF APO AND COMPLEXED ESCHERICHIA-COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE [J].
ALMASSY, RJ ;
JANSON, CA ;
KAN, CC ;
HOSTOMSKA, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :6114-6118
[2]  
[Anonymous], [No title captured]
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase [J].
Banerjee, D ;
Mayer-Kuckuk, P ;
Capiaux, G ;
Budak-Alpdogan, T ;
Gorlick, R ;
Bertino, JR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :164-173
[5]   THE TRANSFORMYLASE ENZYMES IN DENOVO PURINE BIOSYNTHESIS [J].
BENKOVIC, SJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1984, 9 (07) :320-322
[6]   CRYSTAL-STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE FROM ESCHERICHIA-COLI AT 3.0 ANGSTROM RESOLUTION - A TARGET ENZYME FOR CHEMOTHERAPY [J].
CHEN, P ;
SCHULZEGAHMEN, U ;
STURA, EA ;
INGLESE, J ;
JOHNSON, DL ;
MAROLEWSKI, A ;
BENKOVIC, SJ ;
WILSON, IA .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 227 (01) :283-292
[7]  
Chu E., 1996, CANC CHEMOTHERAPY BI, P109
[8]   Crystallization and preliminary X-ray diffraction analysis of recombinant hydrolase domain of 10-formyltetrahydrofolate dehydrogenase [J].
Chumanevich, AA ;
Davies, C ;
Krupenko, SA .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1841-1842
[9]  
COOK RJ, 1991, J BIOL CHEM, V266, P4965
[10]  
EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274